Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Maravai LifeSciences Holdings Inc shares valued at $125,750 were sold by ORESHACK KURT on Jan 31 ’25. At $5.03 per share, ORESHACK KURT sold 25,000 shares. The insider’s holdings dropped to 167,618 shares worth approximately $0.54 million following the completion of this transaction.
Also, ORESHACK KURT purchased 25,000 shares, netting a total of over 125,750 in proceeds.
Before that, DeFord John A had added 17,500 shares to its account. In a trade valued at $100,625, the Director bought Maravai LifeSciences Holdings Inc shares for $5.75 each. Upon closing the transaction, the insider’s holdings increased to 17,500 shares, worth approximately $0.23 million.
As published in a research note from Robert W. Baird on February 26, 2025, Maravai LifeSciences Holdings Inc [MRVI] has been rated down from an Outperform to a Neutral and the price target has been revised to $3 from $9. Analysts at Guggenheim started covering the stock with ‘”a Neutral”‘ outlook in a report released in mid December. As of December 05, 2024, Goldman has decreased its “Neutral” rating to a “Sell” for MRVI. Earlier on November 14, 2024, Wolfe Research initiated its rating. Their recommendation was “a Peer perform” for MRVI stock.
Analyzing MRVI Stock Performance
During the last five days, there has been a drop of approximately -20.34%. Over the course of the year, Maravai LifeSciences Holdings Inc shares have dropped approximately -40.37%. Shares of the company reached a 52-week high of $6.21 on 01/08/25 and a 52-week low of $2.93 on 02/25/25. A 50-day SMA is recorded $4.98, while a 200-day SMA reached $7.28. Nevertheless, trading volume fell to 5.0 million shares from 22.69 million shares the previous day.
Support And Resistance Levels for Maravai LifeSciences Holdings Inc (MRVI)
According to the 24-hour chart, there is a support level at 3.04, which, if violated, would cause prices to drop to 2.82. In the upper region, resistance lies at 3.40. The next price resistance is at 3.54. RSI (Relative Strength Index) is 26.08 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.63, which suggests the price will decrease in the coming days. Percent R is at 84.76%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
